Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hirano, Kenichi ^a   Ohgomori, Tomohiro ^a   Kobayashi, Kazuyoshi ^a   Tanaka, Fumiaki ^a   Matsumoto, Tomohiro ^a   Natori, Takamitsu ^b   Matsuyama, Yukihiro ^c   Uchimura, Kenji ^a   Sakamoto, Kazuma ^a   Takeuchi, Hideyuki ^d   Hirakawa, Akihiro ^a   Suzumura, Akio ^d   Sobue, Gen ^a   Ishiguro, Naoki ^a   Imagama, Shiro ^a   Kadomatsu, Kenji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMANASHI GAKUIN UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KERATAN SULFATE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIFESPAN; MICROGLIA; MOTONEURON; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ROTAROD TEST; WEIGHT REDUCTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIGENS, CD86; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HUMANS; KERATAN SULFATE; MICE; MICROGLIA; MUTATION; SPINAL CORD; SULFOTRANSFERASES; SUPEROXIDE DISMUTASE; TIME FACTORS;

MUS;

EID: 84879368100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066969     Document Type: Article

References (25)

1. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillée S, et al. (2003) Wild-Type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113-117.
2. Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
3. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
4. Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, et al. (2008) Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A 105: 7594-7599.
5. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, et al. (2011) Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol 122: 657-671.
6. Henkel JS, Beers DR, Zhao W, Appel SH, (2009) Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 4: 389-398.
7. Liao B, Zhao W, Beers DR, Henkel JS, Appel SH, (2012) Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 237: 147-152.
8. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, et al. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444.
9. Meissner F, Molawi K, Zychlinsky A, (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A 107: 13046-13050.
10. David S, Kroner A, (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12: 388-399.
11. Ponomarev ED, Maresz K, Tan Y, Dittel BN, (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721.
12. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636-640.
13. Frischknecht R, Heine M, Perrais D, Seidenbecher CI, Choquet D, et al. (2009) Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 12: 897-904.
14. Uchimura K, Kadomatsu K, El-Fasakhany FM, Singer MS, Izawa M, et al. (2004) N-acetylglucosamine 6-O-sulfotransferase-1 regulates expression of L-selectin ligands and lymphocyte homing. J Biol Chem 279: 35001-35008.
15. Zhang H, Muramatsu T, Murase A, Yuasa S, Uchimura K, et al. (2006) N-Acetylglucosamine 6-O-sulfotransferase-1 is required for brain keratan sulfate biosynthesis and glial scar formation after brain injury. Glycobiology 16: 702-710.
16. Ito Z, Sakamoto K, Imagama S, Matsuyama Y, Zhang H, et al. (2010) N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J Neurosci 30: 5937-5947.
17. Imagama S, Sakamoto K, Tauchi R, Shinjo R, Ohgomori T, et al. (2011) Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci 31: 17091-17102.
18. Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, et al. (2009) PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326: 592-596.
19. Dickendesher TL, Baldwin KT, Mironova YA, Koriyama Y, Raiker SJ, et al. (2012) NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 15: 703-712.
20. Mizuno H, Warita H, Aoki M, Itoyama Y, (2008) Accumulation of chondroitin sulfate proteoglycans in the microenvironment of spinal motor neurons in amyotrophic lateral sclerosis transgenic rats. J Neurosci Res 86: 2512-2523.
21. Vargas MR, Pehar M, Díaz-Amarilla PJ, Beckman JS, Barbeito L, (2008) Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J Neurosci Res 86: 3515-3525.
22. Rolls A, Shechter R, London A, Segev Y, Jacob-Hirsch J, et al. (2008) Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 5: e171. Available: http://dx.doi.org/10.1371/journal.pmed.0050171. Accessed 19 August 2008.
23. Shechter R, Raposo C, London A, Sagi I, Schwartz M (2011) The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One 6: e27969. Available: doi:10.1371/journal.pone.0027969. Accessed 21 December 2011.
24. Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, et al. (2011) Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One 6: e21108. Available: doi:10.1371/journal.pone.0021108. Accessed 21 June 2011.
25. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, et al. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347-350.